Subscribe
1 December 2012Jurisdiction reportsOtto Licks

New rules for granting pharma patents

In August, the Brazilian vice-commissioner for patents, Julio Cesar Moreira, announced that the Brazilian Patent and Trademark Office (INPI) was implementing new rules in order to reduce the current backlog of patent applications, which averages eight years, to three years, and minimise delays in granting patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

Apple must pay Optis $700m-the biggest patent award in UK history
Patents
Apple must pay Optis $700m-the biggest patent award in UK history
2 May 2025

Editor's picks

Patents
Apple must pay Optis $700m-the biggest patent award in UK history
2 May 2025
Trademarks
Thatchers, Skykick and dupes: What’s on a fashion IP influencer’s radar?
30 April 2025
Patents
Why US patent reform is ‘essential’ for US economic prosperity and security
28 April 2025
Patents
G1/23 ruling: Why a pending EPO decision threatens decade-old products
28 April 2025
Diversity
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
23 April 2025
Trademarks
Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency
22 April 2025

More articles

UK-India trade deal is ‘missed opportunity’, say industry bodies
'Nothing can stand in the way of our work': Ukraine resumes IP system
WATCH: Finding a new balance in IP protection with trade secret protection
Optis v Apple: How the court calculated the royalty rate
Wouter Pors leaves Bird & Bird for boutique Dutch firm
US-China tariffs: What hope is there for IP rightsholders?
Lenovo Global IP Litigation director joins O'Melveny
The good faith test